GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DARE · Dec 31, 2025

Dare Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001401914-26-000004General Corporate

Capex intensity40thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

37.40% · OPTIONAL · VALID

Operating cash generation56thOwn-history percentile · N=9

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-959.61% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

10429.36% · CORE · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

71.29% · CORE · NOT_ENOUGH_HISTORY

Operating margin60thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.operating_margin

-1315.51% · CORE · VALID

R&D intensity11thOwn-history percentile · N=9

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

536.15% · OPTIONAL · VALID

SBC intensity40thOwn-history percentile · N=10

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

145.27% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building

Dec 31, 20230/6 normalizedLevel 3 Sep 30, 20240/6 normalizedLevel 3 Dec 31, 20240/6 normalizedLevel 3 Mar 31, 20250/6 normalizedLevel 3 Jun 30, 20253/4 normalizedLevel 3 Sep 30, 20255/6 normalizedLevel 3 Dec 31, 20255/7 normalizedLevel 3 Mar 31, 20265/7 normalizedLevel 3 Jun 30, 20265/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 7723.34%
Current: 37.40%
Delta: -7685.94%

Cash Generation Increased

Previous: -19546.20%
Current: -959.61%
Delta: 18586.58%

Growth Increased

Previous: -94.57%
Current: 10429.36%
Delta: 10523.94%

Profitability Increased

Previous: -162340.76%
Current: -1315.51%
Delta: 161025.25%

R And D Intensity Decreased

Previous: 51952.61%
Current: 536.15%
Delta: -51416.46%

Sbc Intensity Decreased

Previous: 17817.29%
Current: 145.27%
Delta: -17672.02%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · DARE Fundamental State →Transitioned To · DARE SBC_INTENSITY_DECREASED →Transitioned To · DARE Fundamental State →Transitioned To · DARE CAPEX_INTENSITY_DECREASED →Transitioned To · DARE CASH_GENERATION_INCREASED →Transitioned To · DARE GROWTH_INCREASED →Transitioned To · DARE PROFITABILITY_INCREASED →Transitioned To · DARE R_AND_D_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.